Leef BrandsLEEEF +0.06%30 9-Day RSI is 51.23 as of Jun. 29, 2026. GuruFocus rates LEEEF with a GF Score™ of 30/100 and a GF Value™ of $0.13 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,046 Drug Manufacturers companies, Leef Brands ranks worse than 72.18% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-06-29), Leef Brands's 9-Day RSI is 51.23.
The industry rank for Leef Brands's 9-Day RSI or its related term are showing as below:
LEEEF's 9-Day RSI is ranked worse than 72.18% of 1046
companies
in the Drug Manufacturers industry
Industry Median: 42.83
vs LEEEF: 51.23
Leef Brands (OTCPK:LEEEF) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Leef Brands 9-Day RSI Related Terms
LEEEF vs ZTS, UTHR: 9-Day RSI Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Leef Brands's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leef Brands 9-Day RSI vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Leef Brands's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Leef Brands's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leef Brands (LEEEF) has a 9-Day RSI of 51.23 as of Jun. 29, 2026. According to the industry distribution chart, Leef Brands ranks #755 out of 1046 companies in the Drug Manufacturers industry, placing it in the top 72.2%.
Is Leef Brands' 9-Day RSI too high?
Leef Brands' current 9-Day RSI is 51.23. The Drug Manufacturers industry median 9-Day RSI is 42.83. Leef Brands' value of 51.23 is 19.6% above this industry median. Based on the distribution chart, Leef Brands ranks #755 out of 1046 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Leef Brands has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Leef Brands' 9-Day RSI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Leef Brands ranks #755 out of 1046 companies for 9-Day RSI. This places Leef Brands in the lower half of its industry. The industry median 9-Day RSI is 42.83. Leef Brands' value of 51.23 is 19.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Drug Manufacturers company?
The median 9-Day RSI among Drug Manufacturers companies is 42.83, based on 1,046 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leef Brands's current 9-Day RSI of 51.23 is 19.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median 9-Day RSI is 42.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leef Brands's current 9-Day RSI is 51.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leef Brands stock overvalued right now?
Based on GuruFocus' analysis, Leef Brands (LEEEF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.13, compared to a current price of $0.17 — trading 30.8% above its estimated fair value. The current 9-Day RSI is 51.23 and 19.6% above the Drug Manufacturers industry median of 42.83. Leef Brands' overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Leef Brands (LEEEF), the current 9-Day RSI is 51.23 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leef Brands (LEEEF) Overvalued in 2026?
Based on GuruFocus' analysis, Leef Brands stock appears to be overvalued.
The current stock price of $0.17 is trading 30.8% above its estimated GF Value™ of $0.13.
GuruFocus considers Leef Brands to be Significantly Overvalued.
Key valuation signals for LEEEF:
9-Day RSI: 51.23
GF Value™: $0.13 vs. price of $0.17 (30.8% above fair value)
Industry Position: 19.6% above the Drug Manufacturers median (#755 of 1046)
No single metric tells the full story. See the LEEEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Leef Brands Inc is a vertically integrated cannabis extraction and manufacturing operator based in California. The company operates in two reportable segments: Wholesale concentrates and Retail. The wholesale concentrate segment includes the propagation, nursery, flowering canopy, drying, processing, manufacturing and distribution of cannabis concentrates. The retail segment includes company owned and operated retail cannabis store in the state of California. It derives majority of the revenue from Wholesale concentrates segment.
30GF Score
Get the complete analysis for LEEEF
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LEEEF has been successfully added to your 